Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Night Trader who wrote (9902)	10/21/1997 12:38:00 PM
From: shasta23	Respond to of 32384

feels like we're back to 17th yard line like a couple of weeks ago..stocks sits there at 16 15/16...deja vu... Stefan

To: Night Trader who wrote (9902)	10/21/1997 12:48:00 PM
From: Henry Niman	Respond to of 32384

Volume in LGND is picking up (over 1/4 million) and ask has been raised to 17 (bid is 16 7/8).

To: Night Trader who wrote (9902)	10/21/1997 3:14:00 PM
From: bob zagorin	Respond to of 32384

Martin, thanks for the link. that was the positive that i saw in the deal..lgnd gets to maintain aggressive research with restrained expenses.

To: Night Trader who wrote (9902)	10/21/1997 3:43:00 PM
From: Andrew H	Read Replies (1) \| Respond to of 32384

Thanks for the link, Martin. Some new info here. They say the mystery drug will likely be submitted for approval next year. So Henry's timetable and suggestion that it will bring LGND profitability in 1999 seem quite plausible, depending on the FDA. If the area is cancer, it could well be fast tracked. Also at the time of exercising the option, LGND will have to pay LLY 10M worth of LGND stock at market price. Must say the new target of 24 did not impress me, however, it is about 50% above the current price.